首页> 外文期刊>ACS Omega >Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin
【24h】

Electrostatic Interactions Enable Nanoparticle Delivery of the Flavonoid Myricetin

机译:静电相互作用使黄酮类化菌丝的纳米颗粒递送

获取原文
           

摘要

Flavonoids are natural polyphenolic compounds with myriad biological activities and potential as prophylactic and therapeutic agents. However, poor aqueous solubility and low bioavailability have limited the clinical utility of flavonoids, suggesting that drug delivery systems (DDSs) may improve their clinical relevance. Therefore, loading of a representative flavonoid (i.e., myricetin) into a diblock, polymeric nanoparticle carrier (NPC) DDS with a cationic corona and hydrophobic core was investigated. Absorbance and fluorescence spectroscopy results revealed association constants and standard Gibbs free energy values that align with previously reported values (K _(a) = ~1–3 × 10~(4) M~(–1); ΔG ° = ?5.4 to ?6.0 kcal mol~(–1)), suggesting that NPCs load myricetin via electrostatic interactions. The zeta potential and gel electrophoresis analysis confirmed this loading mechanism and indicated that NPCs improve myricetin solubility >25-fold compared to myricetin alone. Finally, the dual-drug loading of NPCs was tested using a combination of myricetin and a hydrophobic drug (i.e., farnesol). Electrostatic loading of NPCs with myricetin at concentrations ≤1.2 mM did not affect NPC core loading and release of farnesol, thus demonstrating a novel formulation strategy for the dual-drug-loaded NPC. These findings offer key insights into the NPC DDS design that may enhance the clinical relevance of flavonoid-based therapeutic approaches.
机译:黄酮类化合物是具有多种生物活性的天然多酚化合物,以及作为预防性和治疗剂的潜力。然而,差的水溶性和低生物利用度限制了黄酮类化合物的临床用途,表明药物递送系统(DDS)可以改善其临床相关性。因此,研究了将代表性黄酮(即,Myricetin)加入二嵌段,聚合物纳米颗粒载体(NPC)DDS具有阳离子电晕和疏水核心。吸光度和荧光光谱结果揭示了与先前报道的值对准的关联常数和标准GIBBS自由能值( k _(a)=〜1-3×10〜(4)m〜(-1);Δ g°=?5.4至α6.0kcal mol〜(-1)),表明npcs通过静电相互作用载有myricetin。 Zeta电位和凝胶电泳分析证实了这种负载机制,并表明NPC仅与单独的myricetin相比改善霉素溶解度> 25倍。最后,使用Myricetin和疏水性药物(即法律胆汁)的组合测试NPC的双药物负载。浓度≤1.2mm的Myricetin的NPC的静电载荷不影响法鼻肠的NPC核心载荷和释放,从而证明了一种新型药物负载NPC的新配方策略。这些调查结果提供了对NPC DDS设计的关键见解,可能提高基于黄酮类化的治疗方法的临床相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号